AquaBounty Stock Surges 98% After Regaining Nasdaq Compliance
The biotech firm's shares rallied after resolving delisting risk by meeting the exchange's minimum bid price requirement.
AquaBounty Technologies Inc. (NASDAQ: AQB) saw its shares skyrocket over 98% in a dramatic after-hours trading session, after the company confirmed it had regained compliance with Nasdaq's minimum bid price requirement. The stock, which closed the regular session at $1.14, soared to $2.26 on the news, signaling strong investor relief as the immediate threat of the stock being delisted was removed.
The rally was triggered by a where the company announced it had received a notice from Nasdaq confirming compliance. This milestone resolves a significant uncertainty that has loomed over the company since January, when it was first notified of being non-compliant for its stock trading below the required $1.00 per share threshold for 30 consecutive business days.
Investor reaction was swift and decisive, with trading volume surging to more than 100 times the daily average. This spike in activity underscores the importance of maintaining a major exchange listing, which is critical for institutional investment, market liquidity, and overall investor confidence. The move reverses a period of pressure on the stock and marks a significant turnaround, with shares now up more than 80% year-to-date.
With the delisting risk now in the rearview mirror, AquaBounty can turn its full attention to its operational goals. The company, a pioneer in aquaculture biotechnology, is known for its genetically engineered AquAdvantage salmon, which is designed to grow to market size more rapidly than conventional salmon. , this regulatory win allows the leadership team to focus on scaling production and advancing its commercial strategy without the distraction of a potential delisting.